Social Media Influencers Driving Unofficial Market for Unlicensed Slimming Drug
A shadow market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, according to recent findings.
Investigational Drug Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with numerous of participants share comparison images, injection guides and claims of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.
Medical Experts Express Worries
However, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users administering products of uncertain source.
Some experts said the popularity for retatrutide could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
According to the social media company, the service has taken down violative material and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Online Marketplace Operations
Investigations also found groups with up to 9,000 members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, glowing reviews and step-by-step instructions for mixing or administering at home.
Within minutes of entering one community, a seller shared contact information, where most purchases occur. The seller sent an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, health issues or past usage.
Product Information and Costs
Inside these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram stated it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her team has previously seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may subject patients to potentially significant health risks”.
